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Abstract: The present study estimated the 5-year cumulative probability of Nd:YAG laser posterior
capsulotomy according to the diopter power of implanted hydrophobic acrylic intraocular lenses
(IOLs). Data were retrospectively collected of 15,375 eyes having cataract surgery and in-the-bag
implantation of hydrophobic acrylic monofocal IOLs at the Ophthalmology Unit of Kymenlaakso
Central Hospital, Kotka, Finland between the years 2007 and 2016. The cumulative probability
of Nd:YAG capsulotomy was calculated by Kaplan–Meier estimates, and potential risk factors
were analyzed using the Cox proportional hazards model. The 5-year cumulative probability of
Nd:YAG capsulotomy after cataract surgery was 27.4% (95% confidence interval (CI) 22.9–32.6%)
for low-diopter (5–16.5 D) IOLs, 14.6% (13.8–15.5%) for mid-diopter (17–24.5 D) IOLs, and 13.6%
(11.7–15.6%) for high-diopter (25–30 D) IOLs. A multivariate Cox regression analysis showed that
low-diopter IOLs (HR 1.76; 95% CI 1.38–2.25; p < 0.001) were associated with an increased risk of
Nd:YAG capsulotomy compared to mid-diopter IOLs over the follow-up period after accounting for
other predictors. Real-world evidence shows that low-diopter IOLs are associated with significantly
higher risk of Nd:YAG capsulotomy within five years following implantation. Estimation should
help in evaluating the risks of cataract surgery in myopic eyes.
Keywords: cataract surgery; posterior capsule opacification; Nd:YAG capsulotomy; myopia;
low-diopter IOL; retrospective cohort study; ZCB00; PCB00; SN60WF; AU00T0; ZA9003
1. Introduction
Posterior capsular opacification (PCO) due to the proliferation and migration of lens epithelial
cells (LECs) remains the most common long-term complication after cataract surgery, although
advancements in surgical technology appear to have decreased its incidence [1,2]. The risk factors
of PCO have been studied extensively, but the effect of myopia on the incidence of PCO is still not
precisely known.
In recent years, several studies have evaluated the effects of intraocular lens (IOL) design and
materials on prevention of PCO and subsequent Nd:YAG capsulotomy. Results suggest that a sharp
optic edge of the IOL and a firm capsule–IOL adhesion could inhibit LEC migration and PCO [3–5].
Myopic eyes are a particular case in this context since they tend to have large capsular bags and are also
implanted with thinner IOLs; both are factors that may promote the development of a lower contact
pressure between the capsule and IOL. Accordingly, a previous prospective study investigating the
capsule–IOL interaction in emmetropic and highly myopic eyes revealed weak capsular adhesion and
incompletely adhesive types of capsular bend formation in highly myopic eyes, which appeared to
increase the likelihood of PCO during the early 28-day postoperative period [6].
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Low-diopter IOLs and myopic eyes provide an opportunity to understand more about the
relatively unknown nature of postoperative capsule–IOL interaction, which will play an important
role in the development of future IOLs. The aim of our study was to evaluate the real-world 5-year
probability of Nd:YAG capsulotomy according to the diopter power of the implanted hydrophobic
acrylic monofocal IOL.
2. Patients and Methods
This retrospective cohort study was carried out at the Ophthalmology Unit of Kymenlaakso
Central Hospital, Kotka, Finland. The study was approved by the Research Director and Chief Medical
Officer of the Kymenlaakso Central Hospital and the tenets of the Declaration of Helsinki were followed.
We reviewed the registry of operations for phacoemulsification cataract surgeries and Nd:YAG laser
capsulotomies between 3 September 2007 and 15 September 2016. All eyes having phacoemulsification
surgery and in-the-bag implantation of ZCB00 or preloaded PCB00 (Abbott Medical Optics/Johnson
& Johnson Vision Inc., New Brunswick, NJ, USA), SN60WF, or preloaded AU00T0 (Alcon Laboratories
Inc, Fort Worth, TX, USA), and ZA9003 IOLs (Abbott Medical Optics/Johnson & Johnson Vision Inc.)
were included in the study. Indications for Nd:YAG laser capsulotomy were decreased corrected
distance visual acuity and decreased visual function caused by PCO.
Nd:YAG laser capsulotomy was performed with Ellex Super Q YAG laser system (Nova Eye
Medical, Adelaide, Australia). Posterior capsule opening was created most often in a cruciate pattern
using an Abraham Capsulotomy contact lens, which enhances visualization and focusing. Anesthesia
was topical. Patients received postoperative topical IOP-lowering and anti-inflammatory medication
according to the physician’s preference.
For group comparisons regarding the baseline demographic and surgical characteristics,
continuous and normally distributed data (age) were analyzed with the one-way ANOVA F test, and
categorical data (number of patients ≥ 60 years of age, gender, IOL model, and surgeon seniority)
with the Pearson’s chi-square test. Post-hoc comparisons among diopter groups were performed
with ANOVA pairwise comparisons for the age variable and by identifying statistically significant
Pearson’s chi-square adjusted residuals for the categorical variables. Univariate and multivariate
Cox proportional hazards regression modeling was used with a stepwise approach to evaluate the
effect of dioptric power of implanted IOLs and several other variables including the patient’s age, sex,
type of IOL, and the operating surgeon’s seniority on the probability of a Nd:YAG laser capsulotomy
event. The IOLs were categorized as low- (5–16.5 D), mid- (17–24.5 D) and high-diopter (25–30 D)
lenses [7]. The model included all available eyes, but used a robust estimate of the variance of estimated
parameters to account for the correlation between right and left eyes. The cumulative probability
of Nd:YAG laser capsulotomy was estimated by Kaplan–Meier survival analysis. The length of the
follow-up for each eye was until five years after cataract surgery or until the end of the study period.
Statistical analysis was performed using Stata software (version 13.0, StataCorp, College Station, TX,
USA). The significance level was set at 5%.
3. Results
A total of 17,691 eyes underwent cataract surgery and 1959 Nd:YAG capsulotomies were carried
out between 3 September 2007 and 15 September 2016. In all, 15,375 eyes were included in the study
according to the inclusion criteria and a total of 1312 Nd:YAG capsulotomies were performed on
these eyes during the follow-up. The median duration of follow-up after surgery was 40 months.
Baseline demographic and surgical characteristics for all eyes are listed in Table 1.
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Table 1. Baseline demographic and surgical characteristics.
Variables All Eyes 5–16.5 D 17–24.5 D 25–30 D p Value
n = 15,375 n = 644 n = 12,313 n = 2418
Age (years) 75.2 ± 9.0 69.2 ± 9.5 a 75.4 ± 8.9 b 75.8 ± 8.8 b <0.001
≥60 years, n (%) 14,399 (93.7) 533 (82.8) * 11,584 (94.1) * 2282 (94.4) <0.001
Gender <0.001
Female 9792 (63.7) 411 (63.8) 7521 (61.1) * 1860 (76.9) *
Male 5583 (36.3) 233 (36.2) 4792 (38.9) * 558 (23.1) *
IOL model <0.001
ZCB00/PCB00 6579 (42.8) 340 (52.8) * 5158 (41.9) * 1081 (44.7)
SN60WF/AU00T0 7098 (46.2) 244 (37.9) 5748 (46.7) 1106 (45.7)
ZA9003 1698 (11.0) 60 (9.3) 1407 (11.4) * 231 (9.6)
Surgeon seniority n = 15,280 n = 636 n = 12,245 n = 2399 0.045
Specialist 14,170 (92.7) 604 (95.0) 11,329 (92.5) 2235 (93.2)
Resident 1112 (7.3) 32 (5.0) 916 (7.5) 164 (6.8)
Data are given as mean ± SD for continuous variables and absolute numbers (with proportions) for categorical
variables. a,b Different superscripts indicate significant differences between the groups in ANOVA post-hoc pairwise
comparisons after Bonferroni correction. * Asterisk indicates statistically significant Pearson’s chi-square adjusted
residuals after Bonferroni correction. p values ≤ 0.05 were considered significant (in bold).
The cumulative probability of Nd:YAG capsulotomy at five years after cataract surgery was
(95% CI 22.9–32.6%) for low-diopter (5–16.5 D) IOLs, 14.6% (95% CI 13.8–15.5%) for mid-diopter
(17–24.5 D) IOLs, and 13.6% (95% CI 11.7–15.6%) for high-diopter (25–30 D) IOLs (Figure 1).
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Univariate and multivariate Cox proportional hazards regression analyses of potential risk factors
associated with Nd:YAG capsulotomy are shown in Table 2. Implantation of low-diopter IOLs was
associated with a 76% increase in the hazard of Nd:YAG capsulotomy (HR 1.76; 95% CI 1.38–2.25;
p < 0.001), compared to mid-diopter IOLs after accounting for other predictors. Patient age younger
than 60 years (HR 1.41; 95% CI 1.14–1.73; p = 0.001) and female sex (HR 1.21; 95% CI 1.06–1.38; p = 0.006)
were also associated with an increased risk of Nd:YAG capsulotomy over the follow-up period, whereas
implantation of SN60WF/AUT00T0 (HR 0.63; 95% CI 0.56–0.72; p < 0.001) or ZA9003 (HR 0.53; 95% CI
0.44–0.65; p < 0.001) in comparison with ZCB00/PCB00 IOLs was associated with a decreased risk.
Table 2. Crude and adjusted Cox regression analysis of potential risk factors associated with
Nd:YAG capsulotomy.
Risk Factor Crude HR (95% CI) p Value Adjusted * HR (95% CI) p Value
Age (years)
<60 1.55 (1.27–1.89) <0.001 1.41 (1.14–1.73) 0.001
≥60 1.00 1.00
Sex
Female 1.12 (0.99–1.28) 0.077 1.21 (1.06–1.38) 0.006
Male 1.00 1.00
IOL model
SN60WF + AU00T0 0.63 (0.55–0.72) <0.001 0.63 (0.56–0.72) <0.001
ZA9003 0.53 (0.44–0.65) <0.001 0.53 (0.44–0.65) <0.001
ZCB00 + PCB00 1.00 1.00
IOL power (diopters)
5–16.5 1.92 (1.52–2.44) <0.001 1.76 (1.38–2.25) <0.001
17–24.5 1.00 1.00
25–30 0.89 (0.75–1.06) 0.192 0.85 (0.71–1.01) 0.062
Surgeon
Specialist 1.22 (0.90–1.66) 0.193
Resident 1.00
* Final multivariate Cox regression model with stepwise approach included 15,280 observations. p values ≤ 0.05
were considered significant (in bold). HR = hazard ratio.
4. Discussion
The current study showed that the need for Nd:YAG capsulotomy to treat PCO was approximately
two times higher for patients implanted with low-diopter IOLs compared to higher diopter IOLs.
Although the overall incidence of PCO has decreased with advancements in modern cataract surgery,
some patient groups are at higher risk. Our results support the conclusion of a previous prospective
study that the risk of PCO may be higher in myopic eyes because of weak and incomplete capsule
adhesion to the IOL [6].
It is widely recognized that myopia is associated with the development of nuclear cataract [8,9].
However, knowledge of the effect of myopia on PCO is inconclusive. In some studies, a high incidence
of PCO or Nd:YAG capsulotomy in moderately or highly myopic eyes has been observed [10,11].
A previous small prospective trial concluded that axial myopia did not significantly increase the area
or incidence of PCO at four years, although the percentage of eyes with PCO behind the central 3.0 mm
zone of the posterior capsule was higher in the myopia group [12]. Varied results in published studies
can be at least partially attributed to different definitions of myopia such as based on certain axial
length, preoperative refraction, or the diopter power of the IOL implanted. The low-diopter IOL
group in our study was defined according to an estimation of the IOL power in eyes with axial length
≥25.2 mm and the available diopter range of the included IOLs [7,13]. In another previous study
assessing the refractive effects and incidence of complications of refractive lens exchange, high myopia
was defined by implantation of an IOL with a power < 11.0 D [14].
Several mechanisms responsible for PCO formation in myopic eyes have been suggested.
Certain growth factors present in the aqueous humor of pathologically myopic eyes have been
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proposed to influence the development of PCO [12]. There is considerable evidence that firm contact
between the capsule and IOL inhibits the migration of LECs [15]. Previous studies on IOL design and
material have demonstrated a reduced risk associated with sharp-edged hydrophobic acrylic IOLs [4,16].
This supports the idea that the contact pressure between the optic edge and the posterior capsule
is an important factor inhibiting LECs migration. Zhao et al. showed that weak capsular adhesion
and incompletely adhesive types of capsular bend at the optic edge during the early postoperative
period were more common in highly myopic eyes compared to emmetropic eyes [6]. Highly myopic
eyes have large capsular bags and these eyes are also implanted with thinner low-diopter IOLs [17].
Low-diopter IOLs also have reduced posterior convexity. Weak capsular apposition of the IOL could
therefore increase the incidence of PCO in myopic eyes.
In a multivariate analysis, younger age, female gender, and implantation of ZCB00/PCB00
IOLs increased the risk of capsulotomy. These results are consistent with the findings of previous
studies [2,18–21]. Differences in health behavior across age groups and by gender may explain the
findings. Risk differences between the hydrophobic IOLs can be attributed to the effects of IOL design
and biomaterial composition.
There are several strengths and weaknesses related to this study. The study has a large sample
size, which is representative of the population and the length of follow-up was sufficiently long.
The retrospective cohort design allows for the assessment of the natural history of the disease as well
as temporal relationships of risk factors and outcomes. The study also focused on commonly used
IOLs. Thus, the results of this study offer real-world clinical practice evidence. The findings are
relevant because myopic eyes are already at increased risk for retinal detachment just after cataract
surgery alone, and with laser capsulotomy, that rate will probably increase [22]. By also considering
the other risks of laser treatment such as IOL damage and cystoid macular edema, and its economic
burden to health services and society, finding preventive measures reducing the incidence of PCO and
subsequent Nd:YAG capsulotomy would be helpful [23,24].
This study also has potential limitations. In relation to the retrospective design, the results may be
affected by some unknown confounding factors and there may be gaps in the study data. Some common
systemic and ocular comorbidities were not accounted for in the analysis. The completeness of patient
follow-up cannot be fully ascertained because, for example, a patient may have moved out of the
region during follow-up. Some patients could also have sought PCO treatment elsewhere instead of the
hospital clinic, which would lead to an underestimation of the likelihood of the Nd:YAG capsulotomy.
However, we estimate that this proportion is small given the funding of the national healthcare system,
physician care practices, and the health services available in the region. Eyes with refractive myopia
attributed to the cornea or lens, rather than axial myopia, may not exhibit weak postoperative capsular
apposition of the IOL. Some of the patients with high or moderate preoperative myopia may have
been operated with a target of mild myopia (up to −2.5 D), which enables the patients to maintain
a near-sighted lifestyle. Myopic target refraction requires a slightly higher powered IOL, which could
have resulted in classifying some myopic patients near the 16.5 D threshold into the mid-diopter group.
Indications for Nd:YAG capsulotomy in this study were decreased visual acuity and visual function,
but the clinician’s threshold for intervention may have been higher in low-diopter group because of
the higher risks associated with myopic eyes. Nd:YAG capsulotomy rate is not a direct measure for
PCO and is also affected by the patient’s tolerance to PCO-induced symptoms and clinical treatment
practices, but nevertheless, provides a functional indicator of morbidity related to PCO.
The postoperative capsule–IOL interaction is an interesting research topic that will help to develop
better IOLs for the future. For an accommodating IOL that changes its shape, the capsule bag
should remain as elastic as possible after surgery, avoiding fibrotization. Capsular contraction and
myopia may also lead to IOL subluxation requiring innovative solutions for repair [25]. Our study on
low-diopter IOLs elucidates the relationship of PCO and myopia. Future research should also address
the risk–benefit ratio of Nd:YAG capsulotomy, especially in highly myopic eyes including zero-power
and minus-power IOLs, and preferably in a prospective randomized study setting. With regard to
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establishing further epidemiologic evidence of a causal relationship between axial myopia and PCO
formation, a dose–response relationship between the two should be demonstrated using methods of
direct assessment of PCO severity.
In conclusion, the results of this study showed that the estimated risk of Nd:YAG capsulotomy
with low-diopter IOLs is significantly higher compared to higher diopter IOLs. The 5-year real-world
results of this study should help in evaluating the risks of cataract surgery in myopic eyes.
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